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Background: In the current information age, the use of data has become essential for decision making in public
health at the local, national, and global level. Despite a global commitment to the use and sharing of public
health data, this can be challenging in reality. No systematic framework or global operational guidelines have been
created for data sharing in public health. Barriers at different levels have limited data sharing but have only been
anecdotally discussed or in the context of specific case studies. Incomplete systematic evidence on the scope and
variety of these barriers has limited opportunities to maximize the value and use of public health data for science
and policy.
Methods: We conducted a systematic literature review of potential barriers to public health data sharing.
Documents that described barriers to sharing of routinely collected public health data were eligible for inclusion
and reviewed independently by a team of experts. We grouped identified barriers in a taxonomy for a focused
international dialogue on solutions.
Results: Twenty potential barriers were identified and classified in six categories: technical, motivational, economic,
political, legal and ethical. The first three categories are deeply rooted in well-known challenges of health information
systems for which structural solutions have yet to be found; the last three have solutions that lie in an international
dialogue aimed at generating consensus on policies and instruments for data sharing.
Conclusions: The simultaneous effect of multiple interacting barriers ranging from technical to intangible issues has
greatly complicated advances in public health data sharing. A systematic framework of barriers to data sharing in
public health will be essential to accelerate the use of valuable information for the global good.
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Public health decision making has become increasingly
complex and the use of data has become essential in this
information age [1]. At the local level, data are used to
monitor population health and to target interventions; at
the national level, data are used for resource allocation,
prioritization, and planning; and at the global level for
estimates on the global burden of disease, to measure
progress in health and development, and to contain emer-
ging global health threats [2-7]. In addition to their pri-
mary use by public health agencies, routinely collected* Correspondence: wav10@pitt.edu
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article, unless otherwise stated.public health data have become valuable for secondary use
such as academic research and technology development.
Recently, global health and funding agencies have made
appeals for greater availability and access to granular pub-
lic health data [2,8] and have developed principles for data
sharing in global health [8,9].
Benefits of data sharing have been widely recognized –
transparency and cooperation, reproducibility of research,
cost-efficiency and preventing redundancies, acceleration of
discovery and innovation, and saving lives through more
efficient and effective public health programs [5,10-12].
Despite a growing global commitment to the use and shar-
ing of public health data, this can be challenging in reality.
For example the global polio eradication initiative (GPEI)
could benefit from more widely available genetic sequencentral Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/4.0), which permits unrestricted use,
, provided the original work is properly credited. The Creative Commons Public
mons.org/publicdomain/zero/1.0/) applies to the data made available in this
van Panhuis et al. BMC Public Health 2014, 14:1144 Page 2 of 9
http://www.biomedcentral.com/1471-2458/14/1144data to reconstruct chains of transmission, and estimates
made by the global burden of disease project (GBD) and
the Millennium Development Goals (MDG) would be more
accurate if better quality data would be available from parts
of the world [2,5,6,13,14]. Even at the local level, the
efficient use and sharing of data among different agencies
can be a challenge.
The field of public health is highly interdisciplinary
and includes a wide range of data sources that is always
evolving in size and complexity. Much data is derived
directly from populations monitored by health agencies
such as from clinical records and demographic and
survey data. In addition, many auxiliary data sources are
used to measure determinants of health such as environ-
mental, climate, social behavior, transport, and other
types of data [4]. Although overlap exists across types of
data, this paper will focus on routinely collected popula-
tion derived public health data such as disease surveil-
lance data, intervention coverage data, vital statistics and
cause specific mortality data. These represent some of
the most widely collected, but also some of the most un-
derused data sources in public health science and policy.
A global policy framework or operational guidelines
for data sharing in public health have not yet been devel-
oped for most types of data. For example census and
survey data are increasingly shared through centralized
platforms such as the International Household Survey
Network (IHSN) [15] or the International Public Use
Microdata Series [16], but progress in sharing of disease
surveillance data or cause specific mortality data has
been slow. Many potential and real barriers to sharing of
public health data have been recognized such as privacy
issues or legal constraints but so far have only been
anecdotally discussed or presented in the context of
specific examples and case studies. This has led to
disjointed and incomplete evidence on the scope and
variety of challenges that currently limit data sharing.
Unless these barriers are better understood, solutions
may remain ineffective. We conducted a systematic lit-
erature review of potential barriers to data sharing and
used this evidence to group these barriers in a taxonomy
that can be used as a framework to facilitate an inter-
national dialogue on solutions and instruments to ad-
vance data sharing for better population health.
Methods
We conducted a systematic review according to PRISMA
guidelines [17] to identify documents that reported on
barriers to data sharing in public health [see Additional
file 1]. We defined public health data as data that were pri-
marily collected by public health agencies for routine pur-
poses such as disease surveillance or program monitoring
without primary intention of research [4,18-20]. Barriers
were defined as obstacles that could impede or delay datasharing or that could limit the efficiency of data sharing in
public health. Studies describing barriers on clinical (patient
oriented) or research data were excluded. The protocol for
this review has been provided as supporting information
[see Additional file 2].
We searched the MEDLINE database in August 2013
for original English-language research articles using two
different queries. The first query was [“public health”
OR “world health”] AND [“data sharing” OR “data ac-
cess” OR “open access” OR “dissemination” OR “sharing
practices”] AND [“barriers” OR “challenges”]. The sec-
ond query used the following combination of key words:
[“population surveillance” OR “health statistics” or “vital
statistics” or “civil registry” or “health data”] AND [“data
sharing” OR “data access” OR “open access” OR “dis-
semination” OR “sharing practices”] AND [“barriers” OR
“challenges”]. Additional documentation was identified
through the bibliographies of indexed papers and web-
sites of major international agencies such as the WHO,
the US Centers for Disease Control (CDC), and the
Wellcome Trust.
We identified 1350 articles in MEDLINE and 57 arti-
cles from bibliographies and agency websites (Figure 1).
Of these, 232 were duplicate articles and 1018 were ex-
cluded based on title and abstract review. We reviewed
the full text of the remaining 157 papers. Ninety-two
studies were excluded because they focused on clinical
data (32), described tools for data sharing but no barriers
(14), described data sharing but no barriers (35), focused
on research data instead of public health data (10) or fo-
cused on animal health (1). Sixty-five studies were finally
included in this review. All of these studies were initially
read independently by two investigators and an initial
list of barrier descriptions was extracted. This list was
reviewed by domain experts among the authors and
classified into preliminary categories. Experts then
grouped and generalized barrier descriptions within
their categories. Iteratively, a modified list of barriers
was proposed and compared to the original barrier de-
scriptions to preserve the intent of the source docu-
ments. A final taxonomy and description of barriers
emerged from a series of group discussions. For each
barrier, we also categorized available evidence to iden-
tify knowledge gaps. We classified studies published in
peer-reviewed papers or not and presenting empiric-
ally derived evidence (through original data collection
such as interviews, focus groups, etc.) or not.
Results
We identified 20 unique real or potential barriers to data
sharing in public health and classified these in a taxonomy
of six categories: technical, motivational, economic, polit-
ical, legal, and ethical barriers (Table 1). These barriers
and categories describe a landscape of challenges that is
Figure 1 Systematic selection of studies on barriers to public health data sharing from the peer-reviewed and grey literature.
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most evidence (68%) was published in peer-reviewed
sources, less than a quarter (22%) of all the documents
reviewed was based on empirically derived evidence, indi-
cating that a large volume of published expert knowledge
has not yet been translated into scientific evidence.
Technical barriers
These barriers for the most part are well understood as
part of resilient challenges in health information system
capacity and continue to form a major obstacle to the
availability and use of public health data. Solutions to
these barriers have been identified but sustainable imple-
mentation and political/financial commitment have been
limited.
1. Data not collected. As long as severe limitations
persist in public health data collection, data sharing
will not be considered a priority. The WHO Health
Metrics Network, the CDC/USAID Data for
Decision Making project (DDM) and other agencies
have found significant gaps in public health data
systems, in particular in low- and middle income
countries [2-4,21-25]. Disease surveillance systemsin many countries cannot meet standards set by the
2005 International Health Regulations [7,25-30].
Civil registration systems in many countries are
lacking as well [2,6,14,18,22,24,31].
2. Data not preserved or 3, cannot be found. Public
health data are often collected for short-term purposes
such as outbreak detection. Data preservation or
archiving is often not prioritized, especially in
situations of limited capacity and resources
[3,18,32-35]. Even if data have been preserved,
data retrieval systems may be lacking. This is
amplified by relocation of offices, staff turnover,
physical damage to paper or electronic files, computer
viruses, computer theft, etc. [34].
4. Language barrier. Routinely collected public health
data are often recorded in local languages, limiting
the possibility to integrate and use such data
together with other data sets, particularly in an
international context [36].
5. Restrictive data format. Despite major advances in
computational resources in public health, a large
volume of public health data such as disease
surveillance data and administrative data continue to
be collected and preserved in hardcopy paper format
Table 1 Evidence for barriers to sharing of routinely collected public health data
Category Barrier Peer-reviewed Non peer-reviewed
Empirical data Non-empirical*
Technical 1. Data not collected [6,21,24,31] [2,4,7,18,22,14,26-28,30] [3,23,25]
2. Data not preserved [33] [3,32,34,35]
3. Data not found [45] [3,34]
4. Language barrier [36]
5. Restrictive data format [40] [3,34,36-39,41]
6. Technical solutions not available [42] [37]
7. Lack of metadata and standards [21,24,43] [40,44,45] [1,35-37,39,41,46]
Motivational 8. No incentives [27,45,49] [35]
9. Opportunity cost [51,52] [13,33,50,53] [35]
10. Possible criticism [33] [32]
11. Disagreement on data use [21] [49]
Economic 12. Possible economic damage [7,26,27,30] [55]
13. Lack of resources [56,21] [13,27,28,30,42,53,57] [3,23,34-36,39,37]
Political 14. Lack of trust [19,59,60] [33,61] [34-37]
15. Restrictive policies [30]
16. Lack of guidelines [45,62,65] [37,41,63,64]
Legal 17. Ownership and copyright [62,65,66,69] [37,63,64,67]
18. Protection of privacy [12,19,59,73,75] [44,57,62,66,72,74] [36,37,64,67,68,70,71]
Ethical 19. Lack of proportionality [76]
20. Lack of reciprocity [51,52] [50,77,78]
Number of unique documents (% of total) 14 (21.5%) 30 (46.2%) 21 (32.3%)
*No or little original data presented.
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incompatible with modern software systems
[3,34,36-41].
6. Technical solutions not available. Technical software
solutions to collect, harmonize (transformation and
recoding to enhance inter-operability), integrate
(combining harmonized datasets), and share com-
plex and heterogeneous data have been developed in
the private or research sector, but have not become
widely available to public health agencies [37,42].
7. Lack of metadata and standards. Oftentimes,
metadata that describe data content, origin, methods,
etc. are lacking for public health data and standards
for data format, variables, and metadata are
insufficiently used, limiting secondary data use and
inter-operability [1,21,24,35-37,39-41,43-46]. Some
advances have been made through the development of
the International Classification of Diseases (ICD) [47],
the Data Documentation Initiative (DDI) and the
Standard Data and Metadata eXchange (SDMX) [48].
These standards are not always used efficiently
however. For example, between 1950 and 2010, up to
20% of deaths in certain countries were attributed to
ill-defined ICD codes [24].Motivational barriers
These include barriers based on personal or institutional
motivations and beliefs that limit data sharing. Solutions
for this group of barriers lie in building trust or develop-
ing transparent legal agreements.
8. No incentives. Data sharing requires time and
resources that are chronically lacking in public
health settings [27,35,37]. Personal and institutional
incentives are often required to prioritize data
sharing over other pressing duties [45,49],
particularly if the benefit of data sharing is delayed
and uncertain (e.g. possibly more efficient disease
control programs) instead of immediately relevant to
data providers (e.g. scientific credit or training).
9. Opportunity cost. Public health officers who have
invested time and effort in data collection could
anticipate that scientific credit or other
opportunities may be lost if data recipients with
greater capacity for analysis could gain the majority
of credit [13,33,35,50-52]. This is a particular
challenge in low resource settings [50,53].
10. Possible criticism. Data providers could be
discredited by errors found during secondary use of
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criticized if data would reveal continued disease
occurrence [32,33]. In the worst case, data sharing
could reveal data fabrication or manipulation. For
example, studies have shown over-reporting of
vaccine coverage by country statistics compared to
independent surveys after introduction of GAVI
incentive funding for vaccination programs [54].
11. Disagreement on data use. Data providers may
disagree with the intended secondary use of their
data or may consider their data inappropriate for a
certain use [49].
Economic barriers
These barriers concern the potential and real cost of
data sharing and solutions depend on the recognition of
data value and on sustainable financing mechanisms.
12. Possible economic damage. Data sharing in public
health is challenged by the economic damage that
this may cause to data providers. Public sharing of
disease outbreak data, for example, can result in
economic damage due to reduced tourism and trade
[7,26,27,30,55]. The global SARS outbreak led to
estimated economic losses of 50 billion USD
between 1998 and 2004 and Foot & Mouth Disease
in the UK resulted in losses of 30 billion USD
between 1998 and 2003 [55]. The possibility of
such significant economic implications due to
(over) reactive market forces could cause great
reluctance among health agencies to rapidly
release disease data.
13. Lack of resources. The process of data sharing
requires human and technical resources for data
preparation, annotation, communication with
recipients, computer equipment, internet
connectivity, etc. [3,21,34,35,42,53]. These resources
are frequently lacking in public sector agencies
under economic pressure or in low income settings
[3,13,21,23,25,28,30,34,36,37,56,57].
Political barriers
These are fundamental structural barriers embedded in
the public health governance system that are grounded
in a political or socio-cultural context. Solutions for
these barriers are not clear-cut and will require global
and national processes to build consensus and political
will.
14. Lack of trust. Trust between a data provider and
user greatly enables data sharing [37]. In the
absence of trust, providers could anticipate
potential misinterpretation, misuse or intentional
abuse of the data [19,33-36,58,59]. For example theIndonesian government refused to share H5N1
influenza samples with the international community
during the 2007 pandemic due to lack of trust on
the potential use of these samples for financial gain
[60]. Legal arrangements were required in the
absence of a trust relationship which led to the
development of the Pandemic Influenza
Preparedness Framework [61].
15. Restrictive policies. Agencies may have developed
official policy guidelines that restrict data sharing,
resulting from various possible underlying factors
such as a general sense of distrust, negative prior
experiences, or other factors [30].
16. Lack of guidelines. Frequently, official guidelines
on data sharing simply do not exist, are unclear or
inconsistent [37,41,45,62,63]. The balance between
making data accessible, safeguarding privacy,
and protecting intellectual, time and financial
investments by public health staff is often not
well regulated or standardized, resulting in
protective policies on sharing of public health
data in general [64,65].
Legal barriers
These barriers are legal instruments used to restrict data
sharing, resulting from the underlying willingness (or not)
to share data. Solutions to this group of barriers include
legal instruments to facilitate data sharing and are highly
dependent on solutions to underlying political barriers.
17. Ownership and copyright. Agencies that collect
public health data are often responsible for the
protection of individual and community privacy and
may feel that a guardianship or ownership role is
bestowed on them by the public [37,66-68]. This
could result in a default of restricting access to
most data [37]. Copyright can be used to restrict
rather than expand access to data. In practice, it is
often not well documented or known who owns
public health data, resulting in inconsistent ad-hoc
guidelines [37,62-65,69]. For example a project in
Canada to integrate National Population Health
Survey data with provincial data required a different
approval process in each province [64].
18. Protection of privacy. Public health agencies have
the mandate and authority to collect private data
from the population governed by the Health
Insurance Portability and Accountability Act
(HIPAA) in the US or similar legislation in other
countries [12,36,37,44,57,59,62,64,66-68,70-73]. A
clear distinction between data containing personal
identifiers and fully anonymous data may not
always be possible, leading to restrictive policies on
all types of data due to privacy concerns
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identifiers may not be sufficiently detailed for
certain applications. Existing tools and standards for
the de-identification of personal identifiers such as
statistical data masking [19] may not be known or
available in many contexts [12,59].
Ethical barriers
These are normative barriers involving conflicts between
moral principles and values. Solutions for these barriers
will involve a global dialogue among all stakeholders on
the ethical principles that should govern data sharing.
19. Lack of proportionality. The issue of proportionality,
the careful deliberation in assessing the risks and
benefits that derive from the amount and type of
data requested compared to the potential impact of
its secondary use, has been identified as a guiding
ethical principle for public health data sharing [9].
Public health agencies may disagree with data
requestors about the proportional risks and benefits
of the secondary use of data and its impact on
public health [76].
20. Lack of reciprocity. Data sharing practices have not
always been fair, and data producers have often
felt exploited in transactions where they receive
little credit or benefit from their work, while
data users that can rapidly analyze data and
publish results benefit from academic credit and
career advancement [77,78] as has happened in
the past [50-52].
Discussion
Using a systematic review of evidence from peer-
reviewed and non peer-reviewed literature, we identified
20 unique real or potential barriers grouped in a tax-
onomy of technical, motivational, economic, political,
legal, and ethical barriers. The complex interactions be-
tween tangible and intangible barriers at different levels
can severely limit the effectiveness of isolated solutions.
Strategies to resolve specific barriers may not advance
data sharing at all if related barriers are not addressed as
well in a comprehensive approach or if more fundamen-
tal barriers remain unchanged. Specific data sharing
strategies should be tailored to different types of data.
We focused this review on routinely collected popula-
tion derived data such as disease surveillance, interven-
tion coverage, or cause specific mortality data. These
types of data are widely collected at ever growing spatio-
temporal resolution and the extended use of this vast
resource for research and policy making could greatly
accelerate public health strategies and programs. The ef-
fective advancement of data sharing in public health will
require a comprehensive understanding of all barriersand a global consensus on the value and on the princi-
ples of data sharing.
Most technical, motivational, and economic barriers
are deeply embedded in much larger challenges of health
information system capacity, particularly in low- and
middle income countries. Solutions are being developed
as part of major international initiatives including infra-
structure development, capacity building, and efficient
financing [14,25,29,31,79]. For example, the need for
sustainable financial mechanisms to create capacity and
infrastructure for collection and sharing of public health
data has been emphasized previously, especially for low
income settings [14,79]. According to Global Fund esti-
mates, 5-10% of program funds should be invested in
data collection, monitoring, evaluation and operational
research [2]. Global health partnerships and disease
specific programs should use ongoing and additional
funding to strengthen public health data systems and
available data could be used more efficiently through
joint use of integrated data for program monitoring
and evaluation [2,3,5,6]. The increased use of stan-
dards and connected electronic data systems can ac-
celerate the collection and integration across countries
of basic longitudinal information such as counts of
disease cases and deaths and coverage of interven-
tions. Investments in such routine data systems will
better position agencies to address ongoing challenges
as well as new public health threats such as the
current Ebola crisis in West Africa [80].
Various initiatives have successfully applied solutions for
sharing of health data, such as the International Household
Survey Network, the Demographic and Health Survey
(DHS), the Multi-Indicator Cluster Surveys (MICS),
and the International Network for the Continuous
Demographic Evaluation of Populations and Their
Health (INDEPTH) [2,81,82]. The solutions imple-
mented by these initiatives should be translated to
routine public health settings.
Political, legal, and ethical barriers will require a differ-
ent approach. These barriers are less tangible and trans-
parent compared to technical barriers and will need to
be clearly outlined and presented for a dialogue across
sectors with international agencies such as the World Intel-
lectual Property Organization (WIPO), the World Health
Organization (WHO), the World Trade Organization
(WTO), countries, development and funding agencies, and
experts in ethics and law [83]. This should lead to the
creation of a political framework in the form of resolutions
or a treaty, and operational guidelines for data sharing in
public health [35,37]. A centralized mechanism such as a
commission or secretariat should monitor, mediate, and
facilitate data sharing among various stakeholders to ensure
a fair and efficient use of data for the advancement of popu-
lation health.
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surveillance or demographic data. More published evi-
dence is needed on sharing of other types of public
health data such as genomic data on emerging pathogens
or cost data of public health interventions. Although we
found the majority of evidence in the peer-reviewed litera-
ture (68%), most documents were based on experience or
ideas (46%) instead of empirically derived information
(22%). Levels of evidence were also different for each bar-
rier. Lack of data collection and metadata and privacy
issues were very well documented while no empirical
evidence was available for other barriers such as data pres-
ervation and format or restrictive policies and data owner-
ship. In-depth formative research is needed to expand the
evidence base of these barriers. As knowledge on these
barriers will increase, so will opportunities for solutions.Conclusion
Great opportunities have been created for global health
cooperation, scientific discovery, and effective disease
control programs by recent advances in public health
data collection. These advancements are contrasted by
real and potential barriers that limit the efficient use of
these data. A global process will be essential for a more
effective use of known solutions and to build consensus
for new solutions to harness the potential of data to-
wards a 21st century population health.Additional files
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